Fucoidan-coated CuS nanoparticles for chemo-and photothermal therapy against cancer

Bian Jang; Madhappan Santha Moorthy; Panchanathan Manivasagan; Li Xu; Kyeongeun Song; Kang Dae Lee; Minseok Kwak; Junghwan Oh; Jun-O Jin

doi:10.18632/oncotarget.23898

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Fucoidan-coated CuS nanoparticles for chemo-and photothermal therapy against cancer

Bian Jang _, Madhappan Santha Moorthy, Panchanathan Manivasagan, Li Xu, Kyeongeun Song, Kang Dae Lee, Minseok Kwak, Junghwan Oh and Jun-O Jin

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2018; 9:12649-12661. https://doi.org/10.18632/oncotarget.23898

Metrics: PDF 2486 views | HTML 7780 views | ?

Abstract

Bian Jang1,2,3,4, Madhappan Santha Moorthy2, Panchanathan Manivasagan2, Li Xu1, Kyeongeun Song1,2, Kang Dae Lee6, Minseok Kwak2,5, Junghwan Oh2,3,4 and Jun-O Jin1

1Shanghai Public Health Clinical Center, Shanghai Medical College, Fudan University, Jinshan District, Shanghai, China

2Marine-Integrated Bionics Research Center, Pukyong National University, Busan, South Korea

3Department of Biomedical Engineering and Center for Marine-Integrated Biomedical Technology (BK21 Plus), Busan, South Korea

4Interdisciplinary Program of Biomedical Mechanical and Electrical Engineering, Busan, South Korea

5Department of Chemistry, Pukyong National University, Busan, South Korea

6Department of Otolaryngology-Head and Neck Surgery, Kosin University College of Medicine, Busan, Korea

Correspondence to:

Minseok Kwak, email: [email protected]

Junghwan Oh, email: [email protected]

Jun-O Jin, email: [email protected]

Keywords: fucodian; copper sulfide nanoparticles; photothermal therapy; chemotherapy; apoptosis

Received: June 21, 2017 Accepted: October 30, 2017 Published: January 03, 2018

ABSTRACT

In advanced cancer therapy, the combinational therapeutic effect of photothermal therapy (PTT) using near-infrared (NIR) light-responsive nanoparticles (NPs) and anti-cancer drug delivery-mediated chemotherapy has been widely applied. In the present study, using a facile, low-cost, and solution-based method, we developed and synthesized fucoidan, a natural polymer isolated from seaweed that has demonstrated anti-cancer effect, and coated NPs with it as an ideal candidate in chemo-photothermal therapy against cancer cells. Fucoidan-coated copper sulfide nanoparticles (F-CuS) act not only as a nanocarrier to enhance the intracellular delivery of fucoidan but also as a photothermal agent to effectively ablate different cancer cells (e.g., HeLa, A549, and K562), both in vitro and in vivo, with the induction of apoptosis under 808 nm diode laser irradiation. These results point to the potential usage of F-CuS in treating human cancer.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 23898

Publication Alerts

Post-Publication Promotion

Research Papers:

Fucoidan-coated CuS nanoparticles for chemo-and photothermal therapy against cancer

Abstract